Hepcidin Levels in Periodontal Health and Disease

NCT03789565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2019-10-04

No results posted yet for this study

Summary

Periodontal disease refers to inflammatory disease of the periodontium caused by the host and/or pathogenic microorganisms. Anti-inflammatory and pro-inflammatory cytokines play a role in the periodontal inflammation process. The aim of this study was to evaluate the levels of hepcidin, interleukin (IL)-6, and IL-10 levels in gingival crevicular fluid (GCF) and in serum samples obtained from individuals with periodontal inflammation.

Conditions

  • Periodontal Diseases

Interventions

OTHER

Biomarker test

Diagnostic biomarker study

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Eligibility

Min Age
32 Years
Max Age
52 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2018-01-20
Completion
2018-02-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03789565 on ClinicalTrials.gov